首页|微波消融对肺癌肿瘤微环境的抗肿瘤作用及其机制

微波消融对肺癌肿瘤微环境的抗肿瘤作用及其机制

扫码查看
目的 探讨微波消融(MWA)对肺癌抗肿瘤的影响与作用机制.方法 将1×106肺癌细胞系3LL皮下注射到6~8周的雄性C57BL/6J小鼠背部两侧,当肿瘤最大径长到7 mm时,随机分为对照组和MWA组,对一侧肿瘤进行MWA处理,每隔1 d监测对侧肿瘤生长.在MWA后的第8天,运用流式细胞术对肿瘤微环境(TME)中免疫细胞群体比例及功能进行分析.在MWA后的1 d腹腔注射程序性死亡受体1(PD-1)或者细胞毒性T淋巴细胞相关蛋白4(CTLA-4)抑制剂(200µg/只),每隔1d监测对侧肿瘤生长.采用独立样本t检验比较两组间差异.使用双向方差分析来比较肿瘤生长曲线.结果 与对照组比较,MWA有效抑制小鼠对侧肿瘤生长,差异有统计学意义(780.70±239.90 比 1 794.00±195.20,t=3.275,P<0.01).MWA 组小鼠对侧 TME 中 CD3+T 细胞(79.02±3.61 比 62.22±3.59,t=3.300,P<0.05)、CD4+T 细胞(33.26±1.73 比 25.80± 1.68,t=2.686,P<0.05)和 CD8+T 细胞(26.26±1.01 比 21.64±1.40,t=3.096,P<0.05)比例显著高于对照组.MWA组小鼠肿瘤浸润Ly6G+MDSC细胞群体比例(33.00±3.25比44.86±1.46,t=3.327,P<0.05)显著低于对照组.对CD4+T细胞的功能以及增殖分析表明,MWA组小鼠γ-干扰素(IFN-γ)+CD4+T 细胞(20.39±1.84 比 3.05±0.47,t=7.827,P<0.01)、TNF-α+CD4+T 细胞(17.25±2.64 比 5.61±1.11,t=3.571,P<0.05)和细胞核增殖抗原(Ki-67)+CD4+T 细胞(90.68±0.81比81.55±1.37,t=6.108,P<0.01)比例显著高于对照组.此外,MWA组小鼠IFN-γ+CD8+T 细胞(37.46±5.09 比 6.84±1.52,t=4.973,P<0.01)和 Ki-67+IFN-γ+CD8+T 细胞(35.75±4.62比6.55±1.48,t=5.204,P<0.01)比例显著高于对照组.对T细胞表面免疫检查点分子表达分析表明,MWA组小鼠T细胞免疫球蛋白及黏蛋白结构域分子3(TIM-3)+CD8+T细胞(25.97±2.30 比 15.57±2.33,t=3.142,P<0.05)和 PD-1+TIM-3+CD8+T 细胞(22.58±2.32 比12.77±2.81,t=2.617,P<0.05)比例显著高于对照组.与MWA单独治疗组比较,将MWA与PD-1(514.50±106.40 比 883.60±144.80,t=1.911,P<0.05)或 CTLA-4(534.40±82.06 比 961.90± 131.00,t=2.941,P<0.05)抑制剂联用显著抑制小鼠对侧肿瘤生长.结论 MWA能够有效抑制肺癌肿瘤生长,将MWA联合PD-1抑制剂或者CTLA-4抑制剂产生更强抗肿瘤效果.
Anti-tumor effect and mechanism of microwave ablation on lung cancer tumor microenvironment
Objective To explore the anti-tumor effect and mechanism of microwave ablation(MWA)on lung cancer.Methods Totally,1 × 106 3LL cells(lung cancer cell line)were subcutaneously injected into both sides of the back of 6-8 week old male C57BL/6J mice.When the maximum diameter of the tumor reached 7 mm,the animals were randomly divided into the control group and MWA group.The tumor on one side was treated with MWA,and the growth of the contralateral tumor was monitored every 1 day.On the 8th day after MWA,flow cytometry was used to analyze the proportion and function of immune cell populations in the tumor microenvironment(TME).After intraperitoneal injection of programmed cell death protein 1(PD-1)or cytotoxic T lymphocyte-associated antigen-4(CTLA-4)inhibitor(200 µg/mouse),the contralateral tumor growth was monitored every 1 day.The independent samples t-test was used to compare the differences between the two groups.Tumor growth curves were compared using two-way ANOVA.Results Compared with the control group,MWA effectively inhibited the growth of contralateral tumors in mice,and the difference was statistically significant(780.70±239.90 vs.1 794.00±195.20,t=3.275,P<0.01).The proportion of CD3+T cells(79.02±3.61 vs.62.22±3.59,t=3.300,P<0.05),CD4+T cells(33.26±1.73 vs.25.80±1.68,t=2.686,P<0.05)and CD8+T cells(26.26± 1.01 vs.21.64±1.40,t=3.096,P<0.05)in the contralateral TME of the MWA group mice was signif-icantly higher than that in the control group.The proportion of tumor-infiltrating Ly6G+MDSC cell popula-tion(33.00±3.25 vs.44.86±1.46,t=3.327,P<0.05)in the MWA group mice was significantly lower than that in the control group.The functional and proliferative analysis of CD4+T cells in the MWA group mice revealed a significantly higher proportion of interferon-γ(IFN-γ)+CD4+T cells(20.39±1.84 vs.3.05±0.47,t=7.827,P<0.01),tumor necrosis factor-α(TNF-α)+CD4+T cells(17.25±2.64 vs.5.61±1.11,t=3.571,P<0.05)and proliferation cell nuclear antigen(Ki-67)+CD4+T cells(90.68±0.81 vs.81.55±1.37,t=6.108,P<0.01)than the control group.In addition,the propor-tion of IFN-γ+CD8+T cells(37.46±5.09 vs.6.84±1.52,t=4.973,P<0.01)and Ki-67+IFN-γ+CD8+T cells(35.75±4.62 vs.6.55±1.48,t=5.204,P<0.01)in the MWA group mice was signifi-cantly higher than that in the control group.Analysis of immune checkpoint molecule expression on the sur-face of T cells showed that compared with the control group,the proportion of T cell immunoglobulin and mucin domain-containing protein 3(TIM-3)+CD8+T cells(25.97±2.31 vs.15.57±2.33,t=3.142,P<0.05)and PD-1+TIM-3+CD8+T cells(22.58±2.32 vs.12.77±2.81,t=2.617,P<0.05)in the MWA group mice was significantly increased in the control group.Compared with the simple MWA treat-ment group,the combination of MWA and PD-1 inhibitors(514.50±106.40 vs.883.60±144.80,t=1.911,P<0.05)or CTLA-4 inhibitors(534.40±82.06 vs.961.90±131.00,t=2.941,P<0.05)significantly inhibited the growth of contralateral tumors,and the difference was statistically significant.Conclusion MWA can effectively inhibit the growth of contralateral lung cancer tumors,and combined use of MWA with PD-1 or CTLA-4 inhibitors produces a more powerful anti-tumor effect.

Microwave ablationLung cancerTumor microenvironmentImmune cellsProgrammed cell death protein 1/Cytotoxic T lymphocyte-associated antigen-4

武少贤、吴悦、房章、伍悠、焦静、陈陆俊、郑晓、蒋敬庭

展开 >

苏州大学附属第三医院肿瘤生物诊疗中心,江苏省肿瘤免疫治疗工程技术研究中心,苏州大学细胞治疗研究院,常州 213003

微波消融 肺癌 肿瘤微环境 免疫细胞 程序性死亡受体1/细胞毒性T淋巴细胞相关蛋白4

国家自然科学基金国家自然科学基金江苏省卓越博士后计划江苏省重点研发计划江苏省自然科学基金江苏省医学重点学科建设项目常州市科技支撑计划社会发展项目

82303164322709552023ZB512BE2022721BK20211065YXZDXK202236CE20235058

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(4)
  • 8